Dr. Chappell is a board certified neurologist with special competence in child neurology. She graduated from Indiana University Medical School completed 2 years of pediatrics and an epilepsy fellowship at the Johns Hopkins Medical Center then returned to Indiana and completed a neurology residency. She was on the faculty in the neurology department of the Indiana University Medical Center until being hired as a clinical research physician by Eli Lilly and Company. She retired from Lilly Research Laboratories in January, 2014, after 25 years designing and conducting clinical trials through all phases of development in many neurological disorders. She was the lead physician for the development of duloxetine for fibromyalgia which resulted in an FDA approval. She is a fellow of the American College of Sports Medicine, a board member of the American Society of Experimental Neurotherapeutics, and a member of the American Academy of Neurology, the Child Neurology Society, and the Society of Tennis Medicine and Science. She continues to practice neurology as a volunteer at the Neighborhood Health Clinic in Naples, FL. Since May, 2018, Dr. Chappell has been a full-time employee of Pharmaceutical Product Development (PPD) as VP of global product development (neuroscience). Dr. Amy was founder and director of the Youth, Sport, Fitness and Health Clinic at the Riley Hospital for Children and the Medical Director of the ATP Tennis Tournament in Indianapolis for nearly 2 decades. In 2014 Dr. Amy joined the Amercian College of Lifestyle Medicine and became certified in The Complete Health Improvement Program (CHIP). She has facilitated multiple CHIP sessions at the Greater Naples YMCA. In 2016 Dr. Amy became certified as a professional plant-based chef by the Rouxbe Cooking School and joined the inaugural class of certified Lifestyle Medicine physicians.